Status: Recruiting
Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP
The purpose of this project is to test a culturally-tailored, community-delivered long-acting injectable PrEP (lenacapavir) program for Latine gay and bisexual men (GBM) and transgender women (TGW). The objective is to evaluate whether this intervention demonstrates greater persistence on lenacapavir for Latine GBM and TGW compared with what has been observed historically at the Duke PrEP Clinic.
Participants needed: 100
Trial details
Phase: Phase 4Age: 18+Biological sex: MaleType: InterventionalSponsor: Duke UniversityUpdated: Feb 2, 2026Locations: 1
Eligibility criteria
Participants must be assigned male sex at birth. [+6]
Individuals living with HIV. [+4]